As of 2026-09-06, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (11.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -219.8%.
The range of the Relative Valuation is (6.26) - (14.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 24.2x | 20.0x |
| Forward P/E multiples | 9.7x - 22.9x | 16.5x |
| Fair Price | (6.26) - (14.25) | (11.38) |
| Upside | -165.9% - -250.0% | -219.8% |
| Date | P/E |